Clinical Competition Candidate
ZIPSOR
ZIPSOR carries use-code patent, moderate complexity (3/5), and meaningful clinical competition (5/5). The listed expiry window is approximately 32 months away. Active clinical competition may compress the generic entry window.
LOE window
32months
to latest listed patent expiry (February 24, 2029)
Expiry attractiveness: 5/5
Patent profile
Substance patent (none)
Product / formulation patent (none)
Use-code patent (listed)
Patent count: 6
Complexity score: 3/5
Clinical competition
Score: 5/5
Active trials linked: 305
Phase 2/3 trials: 94
Higher scores indicate more trial activity for this ingredient — a proxy for competitive generic interest.
Drug overview
Active ingredient: DICLOFENAC POTASSIUM
Applicant (NDA holder): COSETTE PHARMACEUTICALS INC
Confidence: High